Our newsletters
WANECAM2 consortium reports positive results from Phase 2b study of novel treatment for children with malaria
Data from the KALUMI trial show a novel combination of ganaplacide-lumefantrine is efficacious and safe when treating malaria in children
Engaging the community and general public – WANECAM 2 at the week of community engagement in Bamako – Mali
Context The involvement of young girls at all stages of their lives in Science is a major focus of the
MRTC-Parasito PhD workshop for the Thesis Review organised by WANECAM 2
Context As part of its capacity building activities, the WANECAM 2 project has initiated a pedagogical workshop for MRTC-Parasito PhDs
Press release
Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and
The Structural Biology Initiation Workshop co-initiated by BIO-STRUCTURE and WANECAM 2
Context : Most African countries do not conduct research in structural biology due to limited resources, lack of trained people
Workshop for enhancing the PhD research of the Malaria Research and Training Center (MRTC-Parasito), organized by WANECAM 2
Context As part of its capacity building activities, WANECAM 2 initiated a workshop for its PhDs students and extended to